| 567 |
Centers for Disease Control and Prevention |
Html |
en |
Use of Japanese Encephalitis Vaccine in Children:Recommendations of the Advisory Committee on ImmunizationPractices, 2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| travel-associated JE | 0.541975 |
| japanese encephalitis vaccines | 0.501546 |
| je vaccine | 0.99336 |
| United States | 0.489732 |
| endemic areas | 0.504423 |
| culture-derived Japanese encephalitis | 0.481797 |
| seroprotective JE virus | 0.588092 |
| JE-VC | 0.609822 |
| well-defined JE virus | 0.570164 |
| U.S. travelers | 0.480126 |
| unsolicited adverse events | 0.477669 |
| Immunization Practices | 0.494231 |
| Advisory Committee | 0.49441 |
| je-vc immunogenicity | 0.496485 |
| JE-VC Safety Data | 0.48677 |
| neurologic adverse events | 0.482451 |
| children | 0.616038 |
| hypersensitivity adverse events | 0.480478 |
| encephalitis virus vaccines | 0.476766 |
| potential JE virus | 0.589732 |
| JE Epidemiology | 0.564671 |
| JE Vaccine Recommendations | 0.608529 |
| ACIP member roster | 0.474731 |
| pneumococcal conjugate vaccine | 0.498331 |
|
| nonendemic countries | 0.495086 |
| JE disease | 0.542209 |
| injection site tenderness | 0.506772 |
| JE virus | 0.870628 |
| recurrent travelers | 0.50645 |
| ACIP Japanese Encephalitis | 0.490063 |
| Japanese encephalitis vaccine | 0.531079 |
| ongoing JE outbreak | 0.551041 |
| adverse events | 0.678085 |
| virus transmission season | 0.589156 |
| urban areas | 0.519563 |
| ACIP JE Vaccine | 0.674989 |
| JE virus transmission | 0.8112 |
| travelers | 0.620147 |
| short-term travelers | 0.533908 |
| dose | 0.504828 |
| active JE virus | 0.603814 |
| booster dose | 0.478141 |
| primary series | 0.629208 |
| JE-endemic countries | 0.516222 |
| risk | 0.484624 |
| JE virus exposure | 0.624462 |
| japanese encephalitis | 0.589947 |
|
CLICK HERE |
| 4637 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Features: Workplace Safety & Health | CDC Features |
Topic-based listing of CDC Features. Workplace Safety & Health |
| MPEG | 0.276361 |
| PDF | 0.201634 |
| PPT | 0.326381 |
|
| email address | 0.716575 |
| DOC | 0.270026 |
| different file formats | 0.90859 |
|
CLICK HERE |
| 6035 |
Centers for Disease Control and Prevention |
Html |
en |
p-Anisidine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 7339 |
Centers for Disease Control and Prevention |
Html |
en |
Situation Summary on Influenza A (H3N2) Variant Viruses ("H3N2v") | Swine/Variant Influenza (Flu) |
Situation Summary on Influenza A (H3N2) Variant Viruses (“H3N2v”) - CDC |
| variant influenza viruses | 0.851548 |
| swine industry | 0.201646 |
| United States | 0.329139 |
| case count tables | 0.293405 |
| Swine influenza | 0.311935 |
| H3N2v cases | 0.21339 |
| case count | 0.33386 |
| H1N1 pandemic virus | 0.424557 |
| infected pigs | 0.220657 |
| H1N2v viruses | 0.328404 |
| West Virginia | 0.350415 |
| pigs | 0.241963 |
| Swine flu viruses | 0.527342 |
| H3N2v infection | 0.69321 |
| variant viruses | 0.663121 |
| health care workers | 0.293769 |
| U.S. pigs | 0.216508 |
|
| sporadic infections | 0.396776 |
| cases | 0.232966 |
| H3N2 variant viruses | 0.593746 |
| seasonal influenza | 0.253319 |
| seasonal flu | 0.265957 |
| variant viruses. | 0.219628 |
| people | 0.566052 |
| Detected U.S. Human | 0.395091 |
| infected pig coughs | 0.323534 |
| certain chronic conditions | 0.260649 |
| human infections | 0.74956 |
| influenza viruses | 0.957201 |
| high risk | 0.369836 |
| localized outbreaks | 0.335762 |
| Limited human-to-human spread | 0.303483 |
| Limited serologic studies | 0.276613 |
|
CLICK HERE |
| 8716 |
Centers for Disease Control and Prevention |
Html |
en |
Emergency Preparedness for Older Adults - About |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9567 |
Centers for Disease Control and Prevention |
Html |
en |
Estimated Percentages and Characteristics of Men Who HaveSex with Men and Use Injection Drugs - United States,1999-2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| male IDU | 0.667599 |
| risk reduction programs | 0.424885 |
| HIV surveillance systems | 0.398789 |
| new HIV infections | 0.398688 |
| IDU participants | 0.32493 |
| data | 0.516559 |
| data source | 0.309781 |
| injection drug | 0.908774 |
| intensified HIV prevention | 0.330618 |
| male-to-male sexual contact | 0.339452 |
| CDC. Estimated HIV | 0.335732 |
| transmission category | 0.449564 |
| NHBS IDU cycle | 0.497362 |
| HIV infections | 0.431176 |
| HIV risk behavior | 0.336747 |
| sexual contact | 0.402107 |
| NHSS data | 0.317772 |
| adult males | 0.30448 |
| IDU | 0.748105 |
| HIV risk behaviors | 0.338961 |
| Nutrition Examination Survey | 0.316127 |
| HIV positive men | 0.352533 |
| general male population | 0.304688 |
| males | 0.369039 |
| HIV medical care | 0.36586 |
|
| IDU cycle eligibility | 0.382021 |
| NHBS MSM cycle | 0.411891 |
| human immunodeficiency virus | 0.319459 |
| IDU cycle* | 0.329205 |
| HIV case reporting | 0.350374 |
| Medical Monitoring Project | 0.363101 |
| male IDU populations | 0.489466 |
| general household population | 0.314723 |
| United States | 0.377686 |
| MSM/IDU | 0.634716 |
| high-risk IDU | 0.332646 |
| National HIV Surveillance | 0.420948 |
| men | 0.654015 |
| surveillance systems | 0.452665 |
| table | 0.317938 |
| HIV Behavioral Surveillance | 0.421987 |
| drugs | 0.327086 |
| MSM | 0.623877 |
| male-to-male sex | 0.577901 |
| national surveillance systems | 0.321939 |
| National HIV Behavioral | 0.422563 |
| medical care | 0.395732 |
| injection drug users | 0.527469 |
| HIV infection | 0.759755 |
|
CLICK HERE |
| 10401 |
Centers for Disease Control and Prevention |
Html |
en |
Communication Guide for Policy and Environmental Change'State Resources'DHDSP'CDC |
null |
| Environmental Change | 0.655697 |
| Stroke Prevention | 0.807152 |
| Disease Control | 0.607581 |
| disabling | 0.201683 |
| Communication Guide | 0.952608 |
|
| heart disease | 0.990318 |
| new tool | 0.668967 |
| Stroke Addendum | 0.930965 |
| Stroke–free States | 0.662722 |
|
CLICK HERE |
| 11525 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | DBD Bulletin Summer 2012 | Featured Publications |
Division of Bacterial Diseases Bulletin Summer 2012 |
| CDC. Licensure | 0.56383 |
| 13-valent pneumococcal conjugate | 0.642931 |
| diphtheria toxoid | 0.55996 |
| Tdap vaccination program | 0.600518 |
| historical purposes | 0.559807 |
| pneumococcal pneumonia | 0.559391 |
| PLoS One. | 0.556845 |
| Trends Microbiol. | 0.559174 |
| Emerg Infect Dis. | 0.61785 |
| Bordetella pertussis DNA | 0.687809 |
| tetanus toxoid | 0.559513 |
| pneumococcal conjugate vaccine | 0.747369 |
| Invasive pneumococcal disease | 0.608081 |
| Bordetella pertussis | 0.691935 |
| acellular pertussis | 0.657028 |
| Washington State Department | 0.591123 |
| conjugate pneumococcal vaccine | 0.668058 |
| Clin Infect Dis. | 0.630611 |
| Clark TA | 0.604745 |
| current pertussis outbreak | 0.673161 |
| Infect Dis. | 0.671561 |
| pneumococcal polysaccharide vaccine | 0.635283 |
| Gershman KA | 0.555044 |
| Emerg Infect Dis | 0.613677 |
| Pertussis pseudo-outbreak | 0.63811 |
|
| meningococcal vaccine | 0.606163 |
| CDC. Comparison | 0.56032 |
| United States | 0.757255 |
| Neisseria meningitidis serogroup | 0.623118 |
| adult vaccination strategies | 0.596749 |
| MacNeil JR | 0.554378 |
| pathogen Haemophilus haemolyticus | 0.61292 |
| Immunization Practices | 0.557036 |
| Advisory Committee | 0.556772 |
| Messonnier NE | 0.611298 |
| meningococcal disease surveillance | 0.627311 |
| Jordan IK | 0.554213 |
| Pediatr Adolesc Med. | 0.589301 |
| Cohn AC | 0.672832 |
| pertussis infection | 0.632374 |
| Pertussis epidemic | 0.633335 |
| CDC. Updated recommendation | 0.607934 |
| Baughman AL | 0.574381 |
| Clin Vaccine Immunol. | 0.638272 |
| Dunning Hotopp JC | 0.60017 |
| Haemophilus influenzae disease | 0.619947 |
| et al | 0.912993 |
| Pertussis control | 0.652258 |
| pertussis trends | 0.63125 |
|
CLICK HERE |
| 13409 |
Centers for Disease Control and Prevention |
Html |
en |
Introduction of Inactivated Poliovirus Vaccine and Switchfrom Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide,2013-2016 |
Immunization Systems Management Group of the Global Polio Eradication Initiative. |
| trivalent inactivated poliovirus | 0.391167 |
| global IPV supply | 0.404566 |
| polioviruses | 0.768447 |
| environmental surveillance | 0.454984 |
| flaccid paralysis cases | 0.388372 |
| supplemental immunization | 0.719967 |
| oral poliovirus vaccine | 0.406894 |
| polio outbreaks | 0.433211 |
| low vaccination coverage | 0.3862 |
| type | 0.656342 |
| OPV-using countries | 0.386343 |
| IPV | 0.59079 |
| monovalent OPV type | 0.409268 |
| switch | 0.924066 |
| attenuated polioviruses | 0.471872 |
| OPV polioviruses | 0.483492 |
| vaccination coverage | 0.389767 |
| tOPV | 0.721065 |
| new cVDPV2 outbreaks | 0.450322 |
| routine immunization | 0.992343 |
| paralytic polio | 0.692615 |
| wild polioviruses | 0.644037 |
| IPV introduction dates | 0.408418 |
| supplemental immunization campaigns | 0.590944 |
|
| routine immunization efforts | 0.457188 |
| routine immunization schedules | 0.636471 |
| Global Polio Eradication | 0.599518 |
| bOPV | 0.653872 |
| Multiple supplemental immunization | 0.439183 |
| supplemental immunization activities | 0.569433 |
| poliovirus outbreaks | 0.53401 |
| Polio Eradication Initiative | 0.591007 |
| routine immunization delivery | 0.472459 |
| tOPV supplemental immunization | 0.458977 |
| global withdrawal | 0.434742 |
| countries | 0.675119 |
| WPV type | 0.394016 |
| World Health Assembly | 0.552835 |
| routine immunization programs | 0.552099 |
| acute flaccid paralysis | 0.881187 |
| global switch | 0.622179 |
| vaccine-derived polioviruses | 0.463799 |
| low polio vaccination | 0.412764 |
| risk | 0.394152 |
| Health Assembly resolution | 0.393206 |
| outbreaks | 0.608404 |
| supplemental immunization activities* | 0.45078 |
|
CLICK HERE |
| 16317 |
Centers for Disease Control and Prevention |
Html |
en |
Nutrition and the Health of Young People | Healthy Schools |
null |
| total caloric intake.10 | 0.675745 |
| Human Services | 0.651633 |
| Human Brain Mapping. | 0.646746 |
| children | 0.793757 |
| Cancer Society Guidelines | 0.674858 |
| Nutr J. | 0.658858 |
| food insecurity | 0.68698 |
| Nutrition Examination Survey | 0.658333 |
| American Dietetic Association. | 0.790545 |
| MS. Food Insecurity | 0.673589 |
| overall health | 0.61193 |
| adolescents | 0.664376 |
| School health guidelines | 0.683918 |
| National Academies Press | 0.65281 |
| healthy eating | 0.733746 |
| Fewer Liquid Calories | 0.688225 |
| adolescents age | 0.632977 |
| Dietary Guidelines | 0.828005 |
| National Health | 0.602578 |
| Constant F. Water | 0.653394 |
| Dietary Sources | 0.625632 |
| Cancer Journal | 0.602338 |
| Dietary Guidelines Advisory | 0.716398 |
| healthy eating pattern | 0.688193 |
|
| trans fatty acids | 0.665736 |
| American School-aged Children | 0.703649 |
| Guidelines Advisory Committee | 0.784501 |
| United States | 0.744916 |
| Secretary Health | 0.607551 |
| various health conditions.1,2 | 0.701033 |
| poor diet | 0.661884 |
| cognitive performance | 0.647257 |
| solid fats | 0.776935 |
| total fruit intake | 0.706318 |
| Federal Dietary Recommendations | 0.690177 |
| Healthy Food Choices | 0.669198 |
| lower dietary quality | 0.708092 |
| added sugars | 0.674698 |
| Rehm CD | 0.669182 |
| physical activity | 0.721041 |
| Healthy Adolescents | 0.62007 |
| Krebs-Smith SM | 0.658768 |
| et al | 0.948729 |
| Jeffes B. Does | 0.64774 |
| Nutrition Research Reviews. | 0.653432 |
| Beverage Consumption Patterns | 0.66063 |
| 7-year-old children | 0.624478 |
| daily calories | 0.63682 |
|
CLICK HERE |